OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study
Ohad Atia, Zivia Shavit-Brunschwig, Diane R. Mould, et al.
The Lancet. Gastroenterology & hepatology (2022) Vol. 8, Iss. 1, pp. 31-42
Closed Access | Times Cited: 39
Ohad Atia, Zivia Shavit-Brunschwig, Diane R. Mould, et al.
The Lancet. Gastroenterology & hepatology (2022) Vol. 8, Iss. 1, pp. 31-42
Closed Access | Times Cited: 39
Showing 26-50 of 39 citing articles:
Novel pharmacological developments in the management of paediatric inflammatory bowel disease
Zubin Grover, Andrew S. Day
Journal of Paediatrics and Child Health (2024) Vol. 60, Iss. 6, pp. 162-163
Open Access
Zubin Grover, Andrew S. Day
Journal of Paediatrics and Child Health (2024) Vol. 60, Iss. 6, pp. 162-163
Open Access
Therapeutic options for children and young people with moderate-to-severe ulcerative colitis
James J. Ashton, Kwang Yang Lee, Anthi Thangarajah, et al.
Frontline Gastroenterology (2024) Vol. 15, Iss. 5, pp. 387-394
Closed Access
James J. Ashton, Kwang Yang Lee, Anthi Thangarajah, et al.
Frontline Gastroenterology (2024) Vol. 15, Iss. 5, pp. 387-394
Closed Access
Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents
Omar I. Saadah, Turki AlAmeel, Ahmed Al Sarkhy, et al.
Saudi Journal of Gastroenterology (2024)
Open Access
Omar I. Saadah, Turki AlAmeel, Ahmed Al Sarkhy, et al.
Saudi Journal of Gastroenterology (2024)
Open Access
Management and outcomes of histoplasmosis in youth with inflammatory bowel disease in an endemic area
Jonathan Wright, Monica I. Ardura, Jennifer L. Dotson, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Open Access
Jonathan Wright, Monica I. Ardura, Jennifer L. Dotson, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Open Access
Efficacy of vedolizumab and ustekinumab in pediatric‐onset inflammatory bowel disease: A real‐world multicenter study
Selma Rebus, Stéphanie Coopman, D. Djeddi, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Closed Access
Selma Rebus, Stéphanie Coopman, D. Djeddi, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Closed Access
Long‐term follow‐up of children with Crohn's disease and small bowel mucosal lesions detected through video capsule endoscopy
Tytti Jaakkola, Laura Merras‐Salmio, Anne Nikkonen, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Open Access
Tytti Jaakkola, Laura Merras‐Salmio, Anne Nikkonen, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Open Access
Response to FDA draft guidance on pediatric IBD drug approval trials: A consensus statement from the IBD Porto Group
Dan Turner, Richard K. Russell, Eytan Wine, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Open Access
Dan Turner, Richard K. Russell, Eytan Wine, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Open Access
Biologics in the management of pediatric inflammatory bowel disease: When and what to choose
Arghya Samanta, Anshu Srivastava
World Journal of Clinical Pediatrics (2024) Vol. 14, Iss. 1
Closed Access
Arghya Samanta, Anshu Srivastava
World Journal of Clinical Pediatrics (2024) Vol. 14, Iss. 1
Closed Access
Biological agents as attractive targets for inflammatory bowel disease therapeutics
Jia-Chen Xue, Xiao-Ting Hou, Yuwei Zhao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024), pp. 167648-167648
Open Access
Jia-Chen Xue, Xiao-Ting Hou, Yuwei Zhao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024), pp. 167648-167648
Open Access
Novel pharmacological developments in the management of paediatric inflammatory bowel disease: Time for guideline update – A narrative review
Rachel BY Lee, Marco Gasparetto
Journal of Paediatrics and Child Health (2023) Vol. 60, Iss. 6, pp. 168-175
Open Access | Times Cited: 1
Rachel BY Lee, Marco Gasparetto
Journal of Paediatrics and Child Health (2023) Vol. 60, Iss. 6, pp. 168-175
Open Access | Times Cited: 1
Prognosis of pediatric ulcerative colitis after infliximab failure: A multicenter registry‐based cohort study
Ryusuke Nambu, Takahiro Kudo, Nao Tachibana, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 39, Iss. 2, pp. 312-318
Open Access | Times Cited: 1
Ryusuke Nambu, Takahiro Kudo, Nao Tachibana, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 39, Iss. 2, pp. 312-318
Open Access | Times Cited: 1
Safety, Efficacy and Persistence of Advanced Therapies in Inflammatory Bowel Disease: Results from ORIGINS. A Retrospective Observational Study
Bogdan Mateescu, Cristian Gheorghe, Anca Trifan, et al.
Journal of Gastrointestinal and Liver Diseases (2023) Vol. 32, Iss. 4, pp. 444-451
Open Access | Times Cited: 1
Bogdan Mateescu, Cristian Gheorghe, Anca Trifan, et al.
Journal of Gastrointestinal and Liver Diseases (2023) Vol. 32, Iss. 4, pp. 444-451
Open Access | Times Cited: 1
Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease—authors' reply
Ruben J. Colman, Phillip Minar
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 5, pp. 567-568
Open Access
Ruben J. Colman, Phillip Minar
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 5, pp. 567-568
Open Access
Vedolizumab in paediatric IBD: a huge step forward but not there yet
R Klomberg, Lissy de Ridder
The Lancet. Gastroenterology & hepatology (2022) Vol. 8, Iss. 1, pp. 3-5
Closed Access
R Klomberg, Lissy de Ridder
The Lancet. Gastroenterology & hepatology (2022) Vol. 8, Iss. 1, pp. 3-5
Closed Access
